Adagene (ADAG) Cash & Equivalents (2019 - 2026)
Adagene's Cash & Equivalents came in at $127.91 million for the quarter ended Jun 30, 2026, up 103.6% from $62.83 million a year earlier.
Powered by 
Analysis
Adagene (ADAG) Cash & Equivalents (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, Adagene's Cash & Equivalents was $74.52 million, down 12.5% from the prior year.
- Cash & Equivalents has declined in each of the last three years, with a five-year compound annual growth rate of -4.2% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Equivalents was $85.19 million in the year ended Dec 31, 2024 (-40.7%), $143.76 million in the year ended Dec 31, 2023 (-17.6%), $174.39 million in the year ended Dec 31, 2022 (unchanged) and $174.39 million in the year ended Dec 31, 2021 (+88.5%).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Cash & Equivalents since the quarter ended Dec 31, 2023.
- Year-over-year, Cash & Equivalents increased in 1 of the last four quarters, with growth averaging 4.0%.
- The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Dec 31, 2022 (growth of 132.1%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 40.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Adagene | 168.81 Mn | 168.81 Mn | - | 127.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.91 Mn |
| Dec 31, 2025 | 74.52 Mn |
| Jun 30, 2025 | 62.83 Mn |
| Dec 31, 2024 | 85.19 Mn |
| Jun 30, 2024 | 95.67 Mn |
| Dec 31, 2023 | 143.76 Mn |
| Jun 30, 2023 | 128.76 Mn |
| Dec 31, 2022 | 174.39 Mn |
| Jun 30, 2022 | 168.04 Mn |
| Dec 31, 2021 | 75.15 Mn |
| Jun 30, 2021 | 208.27 Mn |
| Dec 31, 2020 | 92.53 Mn |
| Dec 31, 2019 | 16.06 Mn |
API Access
Adagene Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADAG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ADAG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ADAG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();